Personalized Nutrition as Medical Therapy for High-Risk Diseases. Questo articolo non è disponibile.Personalized Nutrition as Medical Therapy for High-Risk Diseases

Personalized nutrition involves the formulation of individualized nutritional recommendations to promote and maintain health based on an individual's genetic makeup and other unique intrinsic and extrinsic factors. Implementing personalized nutrition plans for individuals with certain diseases or who are in danger of developing health conditions could help control the onset and severity of symptoms. Personalized Nutrition as Medical Therapy for High-Risk Diseases offers a practical guide for physicians seeking to provide tailored dietary recommendations to their patients with disease treatment, modulation and prevention in mind.

The book focuses on the biological mechanisms of specific diseases and provides evidence for how personalized nutrition positively impacts them. It explores conditions including cardiovascular diseases, hypertension, hypercholesteromia, diabetes, obesity, Crohn's disease, as well as multiple pediatric, renal and psychological disorders.

Features:

· Includes case studies that document how people respond differently towards food depending on their genetic structure and other factors.

· Discusses genome wide association studies (GWIMS) to understand the interplay between genetic susceptibility and dietary interactions.

· Provides users information to effectively implement personalized nutrition into practice.

· Identifies possible challenges to the implementation of personalized nutritional interventions in a clinical setting.

This book is for medical practitioners and will also appeal to researchers and students.

Nilanjana Maulik is a well-established and highly reputed cardiovascular scientist. She is an expert in the field of vascularization and cardiac regeneration and develops therapeutic strategies for ischemic heart disease. Her laboratory has identified important pro-angiogenic molecules that play an important role in therapeutic angiogenesis using various pre-clinical models and diseased conditions. Her research has advanced knowledge in the areas of angiogenesis and revascularization of the ischemic myocardium. Dr. Maulik received her PhD in Biochemistry from Calcutta University, India. After completion of her PhD, Dr. Maulik joined the Department of Surgery at University of Connecticut Health as a research fellow. She has continued her service there as a faculty member, and was promoted to tenured professor. Dr Maulik also serves as a faculty member in the Cell Biology graduate program at the University of Connecticut Health. She is heavily involved in NIH-funded research all her career. She also serves as an expert (cardiovascular) in the NIH study sections regularly; she frequently gives invited lectures at national and international scientific conferences. She has trained more than 150 scientists/fellows/residents, most of whom are actively engaged in professional careers all over the world. Dr. Maulik is a member of several prestigious societies including the Federation of American Societies for Experimental Biology (FASEB), American Heart Association (AHA), International Society of Heart Research (ISHR), American College of Nutrition (ACN) and International College of Angiology (ICA). Presently, she is on the Editorial boards of several major cardiovascular journals and served as Editor-In-Chief of the prestigious journal -“Molecular Biology Reports”- (Springer Press). She is a Fellow of the International Academy of Cardiovascular Sciences (IACS, Canada), ACN, and AHA. She has published more than 210 original peer- reviewed articles and almost 36 book chapters. She has also edited 4 books on epigenetics, nutrition, and cardiovascular diseases for CRC/Springer press. Lastly, Dr. Maulik has organized several international conferences, symposia and delivered more than 125 lectures all around the world.